share_log

雅各臣科研制药发布2024年度业绩 股东应占溢利2.67亿港元同比增加6.34%

新浪港股 ·  Jun 21 09:16

雅各臣科研制药(02633)发布截至2024年3月31日止年度业绩,该集团期内取得收益14.68亿港元,同比增加15.79%;公司权益持有人应占溢利2.67亿港元,同比增加6.34%;每股基本盈利13.9港仙;拟派发末期息每股3港仙。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment